Client News

Roquefort Therapeutics plc: Investor Presentation
Home / Client News / Roquefort Therapeutics plc: Investor Presentation

Roquefort Therapeutics (LSE:ROQ), the Main Market listed biotech company focused on early-stage opportunities in the biotechnology sector, is pleased to announce that Chairman Stephen West and Chief Scientific Officer Graham Robertson will provide a live presentation giving an Introduction to the Company via the Investor Meet Company platform on Friday, 25th March 2022 at 9am GMT.

The presentation is open to all existing and potential shareholders. Questions can be submitted pre-event via your Investor Meet Company dashboard up until 9am the day before the meeting or at any time during the live presentation.


If you are interested in opening an account with Optiva Securities, please fill in the details on the apply button.


Please ensure that the information you entered is accurate, and that your “Caps Lock” key is set correctly.

Share This